Kerr Holbrook - Mar 6, 2024 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
SVP, Chief Commercial Officer
Signature
/s/ Mojirade James, as attorney-in-fact for Kerr W. Holbrook
Stock symbol
AVNS
Transactions as of
Mar 6, 2024
Transactions value $
$650,265
Form type
4
Date filed
3/7/2024, 05:04 PM
Previous filing
Mar 6, 2024
Next filing
Mar 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Award $700K +36.6K +68.69% $19.14 89.8K Mar 6, 2024 Direct F1, F2
transaction AVNS Common Stock Tax liability -$49.7K -2.62K -2.91% $19.00 87.2K Mar 6, 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents time-based restricted share units (TRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended. The award will vest 1/3 on March 6, 2025, 1/3 on March 6, 2026 and 1/3 on March 6, 2027.
F2 Total beneficially owned includes 149 shares acquired on December 31, 2023 and 782 shares acquired on June 30, 2023 under the Issuer's Employee Stock Purchase Plan.
F3 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of TRSUs awarded to the Reporting Person on March 6, 2023, of which 1/3 vested on March 6, 2024, 1/3 will vest on March 6, 2025 and the remaining 1/3 will vest on March 6, 2026.